CLASS II ONGOING Device recall · Reported 22 Oct 2025 · FDA Enforcement Report

The failure occurs if a user on the Omnipod 5 iOS recalled by Insulet

Insulet is recalling The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a, distributed nationwide in the US. The recall was initiated on 11 Sep 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesOmnipod 5 App Software. UDI: 10385083000459. All software versions 2.X.X
Quantity recalled174,013 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0132-2026
FDA event ID
97597
Recalling firm
Insulet, Acton, MA
Classification
Class II
Status
Ongoing
Recall initiated
11 Sep 2025
FDA classified
10 Oct 2025
Reported
22 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

11 Sep 2025Recall initiated by company
10 Oct 2025Classified by FDA+29 days
22 Oct 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying feature of the iPhone, while simultaneously selecting a single number on the keyboard. This causes the single digit number to duplicate. This could result in errors in manual entry of digits - examples: bolus entry, I:C ratio, bolus calculator, prior to starting the bolus insulin delivery. Therefore, this may result in over delivery of insulin which may cause hypoglycemia.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying feature of the iPhone, while simultaneously selecting a single number on the keyboard.

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying feature of the iPhone, while simultaneously selecting a single number on the keyboard. This causes the single digit number to duplicate. This could result in errors in manual entry of digits - examples: bolus entry, I:C ratio, bolus calculator, prior to starting the bolus insulin delivery. Therefore, this may result in over delivery of insulin which may cause hypoglycemia.

Which lots are affected?

Omnipod 5 App Software. UDI: 10385083000459. All software versions 2.X.X

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Insulet

All 21

Other Insulin Pumps & Glucose Monitors recalls

All 467